A Randomized, Double-blind, Placebo-controlled Study to Assess QTc Interval Prolongation of Standard Dose Aflibercept in Cancer Patients Treated With DocetaxelPierre Maison‐Blanche, E. Magherini, Tuncay Göksel et al.|Journal of Cardiovascular Pharmacology|2013Cited by 5